These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 17090529
1. Phospholipase action of platelet-activating factor acetylhydrolase, but not paraoxonase-1, on long fatty acyl chain phospholipid hydroperoxides. Kriska T, Marathe GK, Schmidt JC, McIntyre TM, Girotti AW. J Biol Chem; 2007 Jan 05; 282(1):100-8. PubMed ID: 17090529 [Abstract] [Full Text] [Related]
2. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles. Marathe GK, Zimmerman GA, McIntyre TM. J Biol Chem; 2003 Feb 07; 278(6):3937-47. PubMed ID: 12466264 [Abstract] [Full Text] [Related]
8. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia. Brites FD, Verona J, Schreier LE, Fruchart JC, Castro GR, Wikinski RL. Arch Med Res; 2004 May 07; 35(3):235-40. PubMed ID: 15163466 [Abstract] [Full Text] [Related]
11. Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1. Bacchetti T, Vignini A, Giulietti A, Nanetti L, Provinciali L, Luzzi S, Mazzanti L, Ferretti G. J Alzheimers Dis; 2015 May 07; 46(1):179-86. PubMed ID: 25720407 [Abstract] [Full Text] [Related]
12. Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients. Phumala Morales N, Cherlermchoung C, Fucharoen S, Chantharaksri U. Clin Chem Lab Med; 2007 May 07; 45(7):884-9. PubMed ID: 17617032 [Abstract] [Full Text] [Related]
13. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme. Min JH, Wilder C, Aoki J, Arai H, Inoue K, Paul L, Gelb MH. Biochemistry; 2001 Apr 17; 40(15):4539-49. PubMed ID: 11294621 [Abstract] [Full Text] [Related]
14. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite. Connelly PW, Draganov D, Maguire GF. Free Radic Biol Med; 2005 Jan 15; 38(2):164-74. PubMed ID: 15607900 [Abstract] [Full Text] [Related]
15. Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS. Bayrak T, Dursun P, Bayrak A, Gültekin M, Kolusarı A, Cakır E, Ozyurt M, Zeyneloğlu HB. Gynecol Endocrinol; 2012 Nov 15; 28(11):874-8. PubMed ID: 22621680 [Abstract] [Full Text] [Related]
16. The paraoxonase 1 (PON1), platelet-activating factor acetylohydrolase (PAF-AH) and dimethylarginine dimethylaminohydrolase (DDAH) activity in the metformin treated normal and diabetic rats. Wójcicka G, Jamroz-Wiśniewska A, Czechowska G, Korolczuk A, Marciniak S, Bełtowski J. Eur J Pharmacol; 2016 Oct 15; 789():187-194. PubMed ID: 27450486 [Abstract] [Full Text] [Related]
17. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome. Rizos E, Tambaki AP, Gazi I, Tselepis AD, Elisaf M. Prostaglandins Leukot Essent Fatty Acids; 2005 Mar 15; 72(3):203-9. PubMed ID: 15664305 [Abstract] [Full Text] [Related]